IM Cannabis Corp. (IMCC.CN)

0.7800 +0.0300 (+4.00%) At close: 01:11PM EDT

IM Cannabis Corp.

Kibbutz Glil Yam
Central District
Tel Aviv 4690500
Israel

https://www.imcannabis.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full Time Employees: 95

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Marc Lustig M.B.A., M.Sc.	Executive Chairman	129.92k	N/A	1974
Mr. Oren Shuster	CEO & Director	476.27k	N/A	N/A
Mr. Uri Birenberg	Chief Financial Officer	325.71k	N/A	1976
Mr. Richard Balla	Chief Executive Officer of Adjupharm	293.97k	N/A	N/A
Advocate Michal Lebovitz Nissimov	General Counsel	N/A	N/A	N/A

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It offers cannabis flowers and strain-specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, minis, and full spectrum extracts offerings under the WAGNERS and BLKMKT brands. The company serves medical patients. IM Cannabis Corp. is headquartered in Tel Aviv, Israel.

Corporate Governance

IM Cannabis Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.